Searched for
IMMUNEEL THERAPEUTICS
Tata-backed MedTherapy claims CAR-T breakthrough with one-day productionTata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...27 May, 2026, 08.27 PM IST- Homegrown cell, gene therapy pioneer ImmunoACT turns profitable in first year of opsImmunoAct, an Indian cell and gene therapy company, has achieved profitability in its first full year, generating ₹62 crore in revenue and ...28 Jul, 2025, 03.50 PM IST
- China’s biotech is redrawing the global pharma map; what India can learnAmerican biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma treatment. Astr...16 Mar, 2025, 10.12 AM IST
- Biocon urges government to exempt cancer, rare-disease drugs from tax in budgetIndia should eliminate tax on drugs for cancer treatment and chronic diseases, urged Biocon's chairperson Kiran Mazumdar-Shaw, ahead of the...20 Jan, 2025, 04.33 PM IST
- Bengaluru company launches low-cost treatment for blood cancerImmuneel Therapeutics, co-founded by Kiran Mazumdar-Shaw, has introduced Qartemi, India's second CAR-T cell therapy, to treat B-cell Non-Ho...20 Jan, 2025, 12.48 AM IST
- ETtech Deals Digest: Startup funding slips 22.5% to $70 million in July second week YoYStartups in Bengaluru raised $70 million in the second week of July, a 22.5% decrease from last year. Funds were raised mostly at the seed ...12 Jul, 2024, 07.58 PM IST
- Difficult to scale up expensive therapy beyond a point: Kiran Mazumdar-ShawCAR-T therapies, previously not available in India, have shown promising results for patients who have exhausted all other means of treatme...03 Feb, 2023, 09.42 PM IST
- Enzene Biosciences raises $50 million to expand ops in India, US marketsIn a press statement, Enzene said it would leverage the fresh funds to enhance its manufacturing capabilities and drive expansion in its co...30 Jan, 2023, 11.04 AM IST
- Why Kiran Mazumdar-Shaw wants this Pulitzer-winner's 'immaculately researched' book to be prescribed in every high schoolThe Biocon boss says this book inspires the reader to delve deeper into the mysteries of cellular science.19 Jan, 2023, 05.13 PM IST
- All diseases are cellular diseases: Dr Siddhartha MukherjeeRenowned oncologist, cancer researcher and Pulitzer Prize-winning author Dr Siddhartha Mukherjee’s latest book The Song of The Cell: An Exp...19 Jan, 2023, 12.49 PM IST
- Why are investors shying away from biotech startups?Investors have largely been risk-averse when it comes to deep-funding biotech startups that have the potential to turn into billion-dollar ...18 Sep, 2022, 12.19 PM IST
- RBI’s new mandate sparks confusion among fintechs; Foxconn may make EVs in IndiaThe regulator’s directive quickly sparked confusion and frustrations among fintech startups, which told us the RBI appears to be giving ban...22 Jun, 2022, 07.12 AM IST
- LeadSquared is the latest SaaS unicorn; Matrix to raise $450M India fundLeadSquared raked in $153 million from WestBridge and others to join the unicorn club21 Jun, 2022, 07.26 PM IST
- Immuneel Therapeutics raises $15 million in fundingImmuneel Therapeutics is working on developing its own pipeline of chimeric antigen receptor T-cell (CAR-T) therapies and other cellular im...21 Jun, 2022, 06.42 PM IST
- Immuneel signs pact with Hospital Clínic de Barcelona to work on cancer therapyThe collaboration opens up opportunities for co-development of advanced assets to be deployed in Spain and India, said Immuneel in a press ...13 Oct, 2020, 03.49 PM IST
Load More
